About this trial
This will be a single center, prospective study designed to evaluate the effect of adaptive servo ventilation therapy on insomnia severity among patients with moderate to severe chronic insomnia.
Eligibility criteria
Qualifiers
≥ 18 years old
Complaint of insomnia when presenting at clinic
Diagnosis of moderate to severe insomnia through the Insomnia Severity Index (ISI) with a score ≥ 15
Meet diagnostic criteria of Insomnia Disorder (per American Academy of Sleep Medicine)
Disqualifiers
Primary complaint of sleep-disordered breathing or issues with apneas during sleep or excessive daytime sleepiness
Pregnant or planning to be pregnant
Any prior diagnosis of severe respiratory disorder or severe sleep disorder such as restless leg syndrome (RLS), idiopathic hypersomnia, or narcolepsy
High risk for moderate to severe OSA based on STOP-BANG score.
Trial design
Treatments tested in this trial
- ASV therapy